The 7 most recent market catalysts affecting $CMPR, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 6, 2026
Corporate Catalyst
Neutral
Impact 55
Cimpress plc Files for Merger Control Approval for Acquisition of ComDaTek GmbH
Cimpress plc has initiated a merger control proceeding with the German Federal Cartel Office for its indirect acquisition of a majority stake in ComDaTek GmbH. This is a standard r…
Nov 3, 2026
Corporate Catalyst
Neutral
Impact 55
Truist Securities Maintains Buy Rating on Cimpress, Lowers Price Target
Truist Securities updated its analyst coverage on Cimpress, reaffirming a 'Buy' rating but significantly lowering its price target from $108 to $90. This adjustment signals that wh…
Oct 29, 2026
Corporate Catalyst
Neutral
Impact 95
Cimpress Reports First Quarter Fiscal Year 2027 Financial Results
Cimpress reported its Q1 FY27 financial results, revealing revenue of $934.1 million, which was marginally below the FactSet consensus of $934.2 million. More critically, the compa…
Jul 31, 2026
Corporate Catalyst
Bearish
Impact 55
Truist Securities Maintains Buy on Cimpress, Lowers Price Target to $108
Truist Securities analyst Youssef Squali maintained a 'Buy' rating on Cimpress (CMPR) but reduced the price target from $110 to $108. This action reflects a slight recalibration of…
Jul 29, 2026
Corporate Catalyst
Bearish
Impact 75
Cimpress shares are trading lower after the company reported worse-than-expected Q4 financial results.
Cimpress's Q4 miss is a direct corporate catalyst, immediately impacting its stock. The 'worse-than-expected' nature suggests a failure to meet analyst and investor expectations, l…
Jul 29, 2026
Corporate Catalyst
Neutral
Impact 75
Cimpress FY2027 Revenue expected to be more than $3.999B vs $3.976B Est
Cimpress's announcement that its FY2027 revenue is projected to exceed analyst estimates by $23 million is a positive signal for investors. This indicates management's confidence i…
Jul 29, 2026
Corporate Catalyst
Bullish
Impact 92
Cimpress Q4 EPS $0.97 Misses $1.22 Estimate, Sales $944.955M Miss $945.650M Estimate
Cimpress reported Q4 earnings of $0.97 per share, significantly missing the analyst consensus of $1.22, a 20.49% deviation. Sales also missed estimates, albeit by a very small marg…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.